2007 FDA Immunization 
Drug Topics
JUNE 25, 2025
2 Currently, there are 3 FDA-approved seasonal influenza vaccines that contain a concentration of mercury, as evident from January 15, 2025, on the CDC website. The use of the preservative used in FDA-licensed vaccines has significantly declined and were developed into single-dose containers instead of multidose.
Pharmacy Times
JULY 29, 2025
According to findings of a study cited by Joober et al, the frequency of papers declaring significant statistical support for their a priori formulated hypotheses increased by 22% between 1990 and 2007 (n = 4656; P < 001).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
APRIL 30, 2023
Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. Subsection 505(q) initially was added by Section 914 of the 2007 FDA Amendments Act (“FDAAA”), Pub.
pharmaphorum
NOVEMBER 29, 2022
Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy. T cells are known to mediate anti-tumor immune responses. For that reason, they have become the key target of immune checkpoint therapies, like PD-(L)1 agents. About the interviewee.
The Thyroid Pharmacist
JUNE 30, 2023
You may be familiar with naltrexone, which is an FDA-approved medication that has been used since the 1980s for opioid withdrawal. However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. Doses of 1.5-4.5
Roots Analysis
MARCH 3, 2022
Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Some of the complement therapeutics, namely Berinert®, Cinryze®, ORLADEYO®, Ruconest® and TAKHZYRO® were approved for the treatment of hereditary angioedema, by the US FDA and the EMA. Conclusion.
The Checkup by Singlecare
SEPTEMBER 18, 2023
But anemia in pregnancy doesn’t only affect the fetus; it can also increase your own risk of cardiac issues and immune system dysfunction and cause potential issues after your baby is born because of the blood loss during childbirth. American Academy of Pediatrics (2007) Folic Acid. Mayo Clinic (2022) Iron.
Expert insights. Personalized for you.
Let's personalize your content